Navigation Links
Superior Patient Clinical Outcomes Confirms DaVita's Leadership Position on Quality Dialysis Care
Date:7/7/2008

DaVita % Favorable

Performance Indicator DaVita National Average to the National

Average

Kt/V < 1.2 5% (1) 9% (2) 44% improvement

(lower is better)

Fistula In Use 50.0% (1) 48.5% (3) 3% improvement

Albumin < 3.5 g/dL 18% (1) 20% (2) 10% improvement

(lower is better)

Mortality 17.0% 18.6% (4) 8.6% improvement

(lower is better)

(1) DaVita Inc., Q1 2008;

(2) 2006 CMS Clinical Performance Measures Report (most recently published

data; results from 2005 calendar year);

(3) Fistula First National Vascular Access Improvement Initiative Website

(http://www.fistulafirst.org), results from December 2007.

(4) 2007 USRDS Annual Data Report (most recently reported data; results

from 2005 calendar year, Table J 16)

"An important part of measuring and tracking our clinical performance is through the DaVita Quality Index, or DQI," explained Dr. Allen Nissenson, DaVita Chief Medical Officer. "The DQI focuses on the performance of seven key clinical parameters, giving physicians a snapshot of how the patients in their clinics are performing. We have seen a clear correlation over the past five years of using the DQI that as overall DQI scores improve, overall mortality decreases."

"By focusing on clinical training and continuous quality improvement, we are able to partner with nephrologists," said Robertson. "As a doctor still in practice myself, I want my patients to feel their best and enjoy their lives. DaVita's tools and teammate training help me reach these goals."

DaVita is a registered trademark of DaVita Inc. All other trademarks are the property of their respective owners.

A
'/>"/>

SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Increasing Sales Productivity Through Superior Sales Force Performance Management
2. By adding graphene, researchers create superior polymer
3. Flurizans Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimers Disease is Superior to That of Aricept
4. Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination
5. Study Reaffirms Superiority of Trofile(TM) Assay
6. Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
7. Number of Patients Treated with an Antibiotic for MRSA Within U.S. Acute Care Hospitals Increased 8 Percent from 2006 to 2007
8. New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients
9. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment
10. Derma Sciences MEDIHONEY(TM) Helps to Save Patients Limb
11. A Perfect Storm Threatens Patient Access to Specialty Medical Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 On July ... Medvedev , presented Russia,s first ... . The Company is developing a unique project called ... BIOCAD develops a number of innovative drugs based on ... The ceremony took place at the International Exhibition "Innoprom ...
(Date:7/10/2014)... , July 10, 2014 /PRNewswire-iReach/ -- Tute ... interpretation, today announced an agreement with Lineagen, ... for Lineagen,s NextStep Dx PLUS.  Lineagen, ... and neurological disorders, currently offers FirstStep Dx ... testing service used by healthcare providers as ...
(Date:7/10/2014)... July 10, 2014   Ceres, Inc . (Nasdaq: ... company, announced today financial results for the three months ... its business. Ceres reported that the company ... performance this growing season in Brazil, which concluded in ... company,s sorghum evaluation areas for part of the growing ...
(Date:7/10/2014)... may help in the fight against terrorism with the ... of explosives with the use of light and special ... and Actuators B: Chemical , the researchers describe a ... concentrations as low as 6.3 ppm (parts per million). ... minutes. , "Traditionally explosives detection has involved looking for ...
Breaking Biology Technology:Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9Detecting trace amounts of explosives with light 2
... Therapeutics is a privately-held, clinical-stage company developing novel ... Company,s lead product, JVS-100, encodes Stromal cell-Derived Factor ... damaged tissue through recruitment of circulating stem cells ... cell death and restoration of blood flow.  Juventas ...
... Reportlinker.com announces that a new market research ... Analytical Tool - Lymphoma ... Summary "Analytical Tool: Lymphoma" offers ... of strategic possibilities that have emerged in lymphoma ...
... of the American Crystallographic Association (ACA) will be held ... Louisiana. Crystallography is the science devoted to exploring the ... complicated molecules. The study of biomolecules, such as proteins ... often calculated by crystallographers using beams of X-rays sent ...
Cached Biology Technology:Juventas Therapeutics Demonstrates JVS-100 Delivery to Patients with Heart Failure is Safe and Provides Clinical Benefit 2Juventas Therapeutics Demonstrates JVS-100 Delivery to Patients with Heart Failure is Safe and Provides Clinical Benefit 3Reportlinker Adds Analytical Tool - Lymphoma 2Reportlinker Adds Analytical Tool - Lymphoma 3Sulfates in extreme places, DNA tied in knots and magnetic cooling at crystallography meeting 2Sulfates in extreme places, DNA tied in knots and magnetic cooling at crystallography meeting 3Sulfates in extreme places, DNA tied in knots and magnetic cooling at crystallography meeting 4
(Date:7/10/2014)... 27, 2014  The American Academy of Forensic ... Standards and Technology (NIST) and the Department of ... and forensic science expert members to the Forensic ... element of the NIST,s Organization of Scientific Area ... first appointments made to the new FSSB that ...
(Date:7/10/2014)... 2014  Aware, Inc. (NASDAQ: AWRE ), ... announced on June 26, 2014 that its Board of ... per share, or approximately $40 million in total.  The ... and a payment date of July 24, 2014.  The ... set an ex-dividend date for this special cash dividend. ...
(Date:7/10/2014)... , July 2, 2014  Unisys Corporation,s (NYSE: ... , Unisys Nederland N.V., today announced that it has been ... implement and manage a new Basic Provision Biometrics solution for ... Unisys won the contract with a solution based on ... software. The term of the contract is up to seven ...
Breaking Biology News(10 mins):Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3
... locals is a key ingredient in the success of marine ... largest-scale study to date of how coastal communities influence successful ... was a critical factor in whether or not a reserve ... local involvement in research and management. The team looked ...
... memory loss and cognitive decline among older people with diabetes, ... more than 900 men and women aged between 60 and ... the age of 40. They found that brain function ... cortisol. Dr Rebecca Reynolds, of the University of Edinburgh,s ...
... Anyone who grew up in a large family likely remembers hearing ... kids to keep it down, research shows that sleep also is ... world. Rebecca Gomez, Richard Bootzin and Lynn Nadel in the ... babies who are able to get in a little daytime nap ...
Cached Biology News:Participaton 'important for healthy marine parks' 2Babies and sleep: Another reason to love naps 2
Form: Concentrated Applications: ELISA...
Form: Concentrated Applications: ELISA...
ANTI S. GROUP AG:H...
... the Flp-In System creates isogenic cell ... levels of the protein of interest. ... Figure 3. In this experiment the ... was subcloned into pcDNA5/FRT and transfected ...
Biology Products: